CANNABIS SUISSE CORP (CSUI) Financials

CSUI

Trailing 12 months to February 28, 2026

Revenue $0 -100.0% YoY

Net Income $108K +107.2% YoY

Operating Cash Flow -$59K -62.2% YoY

Gross Profit $0 +100.0% YoY

Market Cap $481K as of Sep 14, 2026

Price / Sales n/m revenue is not positive, trailing 12 months to February 28, 2026

Price / Earnings 4.5x on $108K net income, trailing 12 months to February 28, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Feb 28, 2026 Reported Apr 20, 2026 Currency USD FYE May

Newest figures come from the 10-Q for Q3 FY2026, filed Apr 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CSUI SEC filings page.

CANNABIS SUISSE CORP (CSUI) reported $0 in revenue over the twelve months to Feb 28, 2026, down 100.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CSUI FY2025 2026-08-30

A negative-equity balance sheet and cash-consuming operations, not sales scale, dominate Cannabis Suisse Corp.’s financial model.

Reported operating cash flow improved from -$164K in FY2023 to -$45K in FY2025, indicating less cash pressure despite continuing losses. That improvement did not represent profitability: FY2025 net loss was -$456K versus operating cash flow of -$45K, so accounting results and cash conversion are being shaped by different items.

The balance sheet worsened structurally: total liabilities rose from $2.2M in FY2024 to $2.4M in FY2025 while assets declined, making leverage the central financial constraint rather than a simple earnings fluctuation. The current ratio fell from 0.5x to 0.3x, showing that short-term assets covered an even smaller share of near-term obligations.

Gross margin moved from -0.2% in FY2024 to 1.9% in FY2025, but the company still recorded an operating loss of -$288K against $22.5K of revenue. The spread indicates that operating expenses, rather than production cost alone, dominate the reported result.

Financial Health Signals

Financial health score not available

CANNABIS SUISSE CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-8.50

CANNABIS SUISSE CORP scores -8.50, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($481K) relative to total liabilities ($2.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

CANNABIS SUISSE CORP passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

CANNABIS SUISSE CORP reported a net loss of $456K while operations used $45K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

CANNABIS SUISSE CORP reported an operating loss of $288K against $63K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

YoY-100.0%

CANNABIS SUISSE CORP generated $0 in revenue in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

EBITDA

-$68K

YoY-4.0%

QoQ+7.6%

CANNABIS SUISSE CORP's EBITDA was -$68K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.0% from the same quarter a year earlier. Against the prior quarter it is up 7.6%.

Net Income

$27K

YoY-8.8%

QoQ+20.2%

CANNABIS SUISSE CORP reported $27K in net income in Q3 2026. This represents a decrease of 8.8% from the same quarter a year earlier. Against the prior quarter it is up 20.2%.

EPS (Diluted)

$0.00

CANNABIS SUISSE CORP earned $0.00 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Cash & Debt

$75

YoY+50.0%

QoQ-97.1%

CANNABIS SUISSE CORP held $75 in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding

71M

YoY0.0%

QoQ0.0%

CANNABIS SUISSE CORP had 71M shares outstanding in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

None of these metrics is reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

CSUI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSUI quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$0	$23K-25.0%	$30K+200.0%	$10K+28.7%	$8K-84.7%	$51K-79.1%	$243K+1291.1%	$17K+5.7%	$17K+16.3%	$14K
Cost of Revenue	$0	$22K-26.6%	$30K+228.0%	$9K+428.6%	$2K-98.3%	$103K-68.7%	$328K+12804.9%	$3K+10.2%	$2K-40.9%	$4K
Gross Profit	$0	$432+744.8%	-$67-108.0%	$834-86.2%	$6K+111.7%	-$52K+38.9%	-$85K-1798.5%	$5K+18.9%	$4K-59.2%	$10K
SG&A Expenses	$247K	$229K+30.9%	$175K+187.8%	$61K-55.2%	$136K	N/A	$174K+3986.8%	$4K+162.9%	$2K-50.6%	$3K
Operating Income	-$283K	-$288K-12.1%	-$257K+25.0%	-$343K-118.1%	-$157K	N/A	-$351K-1445.7%	-$23K-38.4%	-$16K+38.4%	-$27K
EBITDA	N/A	-$284K-12.3%	-$253K+25.3%	-$338K-118.1%	-$155K	N/A	-$331K-1823.0%	-$17K-32.8%	-$13K+46.1%	-$24K
Interest Expense	$65K	$63K+135.8%	$27K+202.3%	$9K-86.1%	$64K+5.4%	$60K	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A
Net Income	$108K	-$456K+61.6%	-$1.2M-237.5%	-$352K-87.1%	-$188K	N/A	-$389K-1612.5%	-$23K-109.7%	-$11K+59.4%	-$27K
EPS (Basic)	N/A	-$0.01+66.7%	-$0.03-200.0%	-$0.010.0%	-$0.010.0%	-$0.01	N/A	$0.00	$0.00	N/A
EPS (Diluted)	—	N/A	N/A	N/A	N/A	N/A	N/A	$0.00	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	36M-31.6%	52M	57M+2326.7%	2M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$8K0.0%	$8K0.0%	$8K0.0%	$8K
Cost of Revenue	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$7K+7.0%	$7K+7.0%	$7K+7.0%	$9K
Gross Profit	$0-100.0%	$0-100.0%	$0-100.0%	$0+100.0%	$144-76.9%	$144-77.0%	$144-77.0%	-$2K
SG&A Expenses	$59K+5.6%	$63K+13.9%	$62K+13.9%	$63K-8.3%	$56K+12.2%	$55K+95.3%	$55K+94.6%	$69K
Operating Income	-$69K-3.9%	-$75K+18.8%	-$85K-13.0%	-$54K+34.7%	-$67K-6.2%	-$92K-82.1%	-$75K-23.5%	-$83K
EBITDA	-$68K-4.0%	-$74K+19.0%	-$83K-13.1%	-$53K+35.1%	-$66K-6.4%	-$91K-83.8%	-$74K-23.9%	-$82K
Interest Expense	$16K0.0%	$16K0.0%	$16K+9.8%	$16K+21.1%	$16K+211.8%	$16K+293.7%	$15K+258.7%	$13K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$27K-8.8%	$22K+342.4%	$14K+102.6%	$44K+104.4%	$30K+143.4%	$5K+109.2%	-$535K-726.3%	-$999K
EPS (Basic)	$0.00	$0.00	$0.00+100.0%	$0.00+100.0%	$0.00	$0.00	-$0.01	-$0.03
EPS (Diluted)	$0.00	$0.00	$0.00+100.0%	N/A	$0.00	$0.00	-$0.01	N/A
Diluted Shares (Avg)	208M+5.1%	206M+5.1%	203M+187.9%	N/A	198M+328.7%	196M+327.2%	71M	N/A

Not reported in any period shown, so not listed: R&D Expenses.

CSUI Balance Sheet

CSUI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Total Assets	$635K-29.2%	$897K+158.9%	$346K	$0-100.0%	$7K-98.3%	$384K+480.7%	$66K+332.0%	$15K-31.1%	$22K
Current Assets	$107K-45.6%	$196K+4080.7%	$5K	$0-100.0%	$2K-98.6%	$157K	N/A	$13K-19.5%	$16K
Cash & Equivalents	$3K-90.0%	$29K+14252.8%	$199	$0	$0-100.0%	$5	N/A	$6K0.0%	$6K
Short-Term Investments	$0	$0	$0	$0	$0-100.0%	$71K	$0	$0	$0
Inventory	N/A	N/A	N/A	$0-100.0%	$2K-97.0%	$58K	N/A	$7K	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$77K+2939.9%	$3K	$0	N/A
Long-Term Investments	$0	$0	$0	$0	$0+100.0%	-$4K-200.0%	$4K	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$66K	$0	N/A
Total Liabilities	$2.4M+8.7%	$2.2M+231.8%	$676K+146.5%	$274K+41.2%	$194K-74.8%	$770K+1570.3%	$46K+103.8%	$23K+72.8%	$13K
Current Liabilities	$326K-14.6%	$381K+14.1%	$334K+21.8%	$274K+41.2%	$194K-72.2%	$698K	N/A	N/A	N/A
Non-Current Liabilities	$2.1M+13.4%	$1.9M+444.3%	$342K	$0	$0-100.0%	$72K	N/A	N/A	N/A
Long-Term Debt	$611K+43.8%	$425K	N/A	N/A	N/A	$69K	N/A	N/A	N/A
Total Equity	-$1.8M-33.9%	-$1.3M-308.5%	-$329K-20.2%	-$274K-46.2%	-$187K+51.5%	-$387K-2038.3%	$20K+372.0%	-$7K-180.6%	$9K
Retained Earnings	-$3.1M-17.5%	-$2.6M-83.9%	-$1.4M-33.1%	-$1.1M-21.5%	-$875K-92.1%	-$455K-587.5%	-$66K-52.2%	-$44K-60.6%	-$27K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$456K-34.1%	$510K-32.2%	$570K-31.6%	$635K-29.2%	$691K+31.4%	$752K+154.8%	$834K+160.8%	$897K+158.9%
Current Assets	$66K-44.2%	$76K-43.9%	$88K-49.4%	$107K-45.6%	$118K+267929.5%	$135K+1845.0%	$175K+3845.5%	$196K+4080.7%
Cash & Equivalents	$75+50.0%	$3K-36.0%	$305-98.8%	$3K-90.0%	$50+13.6%	$4K-24.7%	$26K+1701.4%	$29K+14252.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.2M-13.5%	$2.3M-13.4%	$2.4M-13.1%	$2.4M+8.7%	$2.5M+153.0%	$2.6M+273.2%	$2.7M+285.7%	$2.2M+231.8%
Current Liabilities	$423K+36.1%	$392K+40.8%	$362K+52.7%	$326K-14.6%	$311K-24.1%	$279K-33.7%	$237K-39.3%	$381K+14.1%
Non-Current Liabilities	$1.8M-20.4%	$1.9M-19.8%	$2.0M-19.4%	$2.1M+13.4%	$2.2M+275.4%	$2.3M+726.7%	$2.5M+690.5%	$1.9M+444.3%
Long-Term Debt	N/A	N/A	N/A	$611K+43.8%	$611K	$611K	$611K	$425K
Total Equity	-$1.7M+5.8%	-$1.8M+5.9%	-$1.8M+4.9%	-$1.8M-33.9%	-$1.8M-287.1%	-$1.9M-358.6%	-$1.9M-389.6%	-$1.3M-308.5%
Retained Earnings	-$3.0M+3.5%	-$3.0M+3.5%	-$3.0M+3.0%	-$3.1M-17.5%	-$3.1M-93.6%	-$3.1M-104.1%	-$3.1M-112.0%	-$2.6M-83.9%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

CSUI Cash Flow Statement

CSUI quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Operating Cash Flow	-$59K	-$45K+1.2%	-$46K+72.2%	-$164K-411.0%	-$32K+75.4%	-$131K+54.8%	-$289K-2335.3%	-$12K-85.3%	-$6K+80.1%	-$32K
Depreciation & Amortization	N/A	$4K0.0%	$4K0.0%	$4K+112.3%	$2K-79.3%	$10K-51.9%	$20K+264.7%	$6K+59.6%	$3K+33.2%	$3K
Stock-Based Compensation	N/A	$0-100.0%	$20K-83.9%	$124K	$0	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0	$0	N/A	N/A	$0-100.0%	$71K	$0+100.0%	-$23K
Financing Cash Flow	$59K	$19K-73.8%	$74K-54.9%	$164K+411.6%	$32K-75.4%	$131K-36.7%	$206K+985.2%	$19K+196.9%	$6K-89.4%	$60K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$70	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$18K-52.8%	-$21K-8.0%	-$12K-117.0%	-$9K-2166.0%	-$11K+51.2%	-$19K-3.6%	-$5K-62.7%	-$406+97.7%
Depreciation & Amortization	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%	$1K0.0%
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	N/A
Investing Cash Flow	$0	$0	$0	$0	$0	$0	$0	$0
Financing Cash Flow	$15K+102.0%	$23K+1020.0%	$9K+260.0%	$12K-58.5%	$7K-59.1%	-$3K-111.1%	$3K-44.4%	$29K+131.4%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

CSUI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSUI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Gross Margin	1.9%+2.1pp	-0.2%-8.6pp	8.3%-69.3pp	77.7%	-101.9%	-34.9%-63.5pp	28.6%+3.2pp	25.4%-47.1pp	72.5%
Operating Margin	-1280.1%	-856.5%	-3426.8%	-2022.6%	N/A	-144.7%	-130.3%	-99.5%	-187.9%
Net Margin	-2027.3%	-3955.4%	-3515.5%	-2418.2%	N/A	-160.3%	-130.3%	-65.7%	-187.9%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	-114.0%	N/A	-293.4%
Return on Assets	-71.8%+60.5pp	-132.3%-30.8pp	-101.5%	N/A	N/A	-101.5%-67.1pp	-34.4%+36.5pp	-70.9%+49.3pp	-120.2%
Current Ratio	0.33-0.2x	0.52+0.5x	0.010.0x	0.000.0x	0.01-0.2x	0.23	N/A	N/A	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	2.31	N/A	1.44
Asset Turnover	0.040.0x	0.030.0x	0.03	N/A	7.74+7.1x	0.63+0.4x	0.26-0.8x	1.08+0.4x	0.64

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	N/A	N/A	N/A	N/A	1.9%-6.4pp	1.9%-6.4pp	1.9%-6.4pp	-25.9%
Operating Margin	N/A	N/A	N/A	N/A	-890.5%	-1230.8%	-997.9%	-1103.4%
Net Margin	N/A	N/A	N/A	N/A	393.5%	67.5%	-7134.5%	-13321.1%
Return on Assets	5.9%+1.6pp	4.4%+3.7pp	2.4%+66.6pp	7.0%+118.4pp	4.3%+17.2pp	0.7%+19.2pp	-64.2%-43.9pp	-111.4%
Current Ratio	0.16-0.2x	0.19-0.3x	0.24-0.5x	0.33-0.2x	0.38+0.4x	0.48+0.5x	0.74+0.7x	0.52+0.5x
Asset Turnover	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.010.0x	0.010.0x	0.010.0x	0.01

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$1.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.33), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CANNABIS SUISSE CORP CSUI	FY2025	$23K	-$456K	N/A	$481K	—
BROAD STREET REALTY INC BRST	FY2024	$41.3M	-$14.8M	-35.8%	$3K	—

Where CANNABIS SUISSE CORP Ranks

Frequently Asked Questions

What is CANNABIS SUISSE CORP's annual revenue?

CANNABIS SUISSE CORP (CSUI) reported $23K in total revenue for fiscal year 2025. This represents a -25.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CANNABIS SUISSE CORP's revenue growing?

CANNABIS SUISSE CORP (CSUI) revenue declined by 25.0% year-over-year, from $30K to $23K in fiscal year 2025.

Is CANNABIS SUISSE CORP profitable?

No, CANNABIS SUISSE CORP (CSUI) reported a net income of -$456K in fiscal year 2025.

What is CANNABIS SUISSE CORP's EBITDA?

CANNABIS SUISSE CORP (CSUI) had EBITDA of -$284K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CANNABIS SUISSE CORP have?

As of fiscal year 2025, CANNABIS SUISSE CORP (CSUI) had $3K in cash and equivalents against $611K in long-term debt.

What is CANNABIS SUISSE CORP's gross margin?

CANNABIS SUISSE CORP (CSUI) had a gross margin of 1.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CANNABIS SUISSE CORP's operating cash flow?

CANNABIS SUISSE CORP (CSUI) recorded an outflow of $45K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are CANNABIS SUISSE CORP's total assets?

CANNABIS SUISSE CORP (CSUI) had $635K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does CANNABIS SUISSE CORP have outstanding?

CANNABIS SUISSE CORP (CSUI) had 71M shares outstanding as of fiscal year 2025.

What is CANNABIS SUISSE CORP's current ratio?

CANNABIS SUISSE CORP (CSUI) had a current ratio of 0.33 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is CANNABIS SUISSE CORP's return on assets (ROA)?

CANNABIS SUISSE CORP (CSUI) had a return on assets of -71.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CANNABIS SUISSE CORP's P/E ratio?

CANNABIS SUISSE CORP (CSUI) trades at 4.5x earnings, its market capitalization divided by net income of $108K net income, trailing 12 months to February 28, 2026. The market capitalization is $481K as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CANNABIS SUISSE CORP's price-to-sales ratio?

CANNABIS SUISSE CORP (CSUI) has no price-to-sales ratio at the moment: revenue is not positive (trailing 12 months to February 28, 2026). The market capitalization is $481K as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does CANNABIS SUISSE CORP's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, CANNABIS SUISSE CORP (CSUI) held $3K in cash, cash equivalents and investments, and reported an operating cash outflow of $45K over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is CANNABIS SUISSE CORP's debt-to-equity ratio negative or not reported?

CANNABIS SUISSE CORP (CSUI) has negative shareholder equity of -$1.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is CANNABIS SUISSE CORP's Altman Z-Score?

CANNABIS SUISSE CORP (CSUI) has an Altman Z-Score of -8.50, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is CANNABIS SUISSE CORP's Piotroski F-Score?

CANNABIS SUISSE CORP (CSUI) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CANNABIS SUISSE CORP's earnings high quality?

CANNABIS SUISSE CORP (CSUI) reported a net loss of $456K while operations used $45K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CANNABIS SUISSE CORP cover its interest payments?

CANNABIS SUISSE CORP (CSUI) reported an operating loss of $288K against $63K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.